SCHEMBL6662940

SCHEMBL6662940

C=C(C)C(=O)Oc1cccc2c1C(=O)C=CC2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 3/20 0.60
POLM Q9NP87 2/20 0.56
POLK Q9UBT6 2/20 0.56
POLL Q9UGP5 2/20 0.56
POLH Q9Y253 2/20 0.56
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 3/20 0.46
KDM4E B2RXH2 2/20 0.46
USP2 O75604 2/20 0.46
TP53 P04637 2/20 0.46
HPGD P15428 2/20 0.46
MAPK1 P28482 2/20 0.46
CASP7 P55210 2/20 0.46
IDO1 P14902 2/20 0.46
CDC25B P30305 2/20 0.46
PIN1 Q13526 2/20 0.46
AURKA O14965 1/20 0.46
TRPA1 O75762 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287104 0.85 TOP1 (0.65) TOP1POLMPOLKPOLLPOLH
SCHEMBL17439481 0.82 TOP1 (0.49) TOP1POLMPOLKPOLLPOLH
SCHEMBL29117714 0.79 ELANE (0.45) TOP1KMT2AALDH1A1MAPTMEN1
SCHEMBL8622400 0.78 TTR (0.56) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL11908091 0.78 ELANE (0.39) TOP1POLMPOLKPOLLPOLH
SCHEMBL3054875 0.78 POLM (0.63) TOP1POLMPOLKPOLLPOLH
SCHEMBL28633753 0.77 KDM4E (0.50) TOP1KMT2AALDH1A1MAPTMEN1
SCHEMBL19798278 0.76 PIM1 (0.73) TOP1POLMPOLKPOLLPOLH
SCHEMBL17460659 0.76 MAOA (0.56) KMT2AALDH1A1MAPTMEN1KDM4E
SCHEMBL10399814 0.76 ELANE (0.51) KMT2AALDH1A1KDM4EHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080300298-A1 Honokiol Derivates For the Treatment of Proliferative Disorders NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
US-20080300298-A1 Honokiol Derivates For the Treatment of Proliferative Disorders NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed
WO-2004003609-A1 METHOD FOR PRODUCING INTEGRATED WAVEGUIDES, POLYMER SYSTEMS FOR PRODUCING SUCH WAVEGUIDES, AND METHOD FOR PRODUCING PLANAR WAVEGUIDE CHANNELS ATOTECH DEUTSCHLAND GMBH (DE) 2004-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300298-A1 Honokiol Derivates For the Treatment of Proliferative Disorders CCNK, CDK3, CCNO TOP1 663/4885POLM 1171/4885POLK 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.